PRIMARY PERITONEAL CANCER
Clinical trials for PRIMARY PERITONEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new PRIMARY PERITONEAL CANCER trials appear
Sign up with your email to follow new studies for PRIMARY PERITONEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested for Tough-to-Treat ovarian cancer
Disease control CompletedThis study tested an experimental drug called RC88 in women whose ovarian, fallopian tube, or primary peritoneal cancer had returned and was no longer responding to standard platinum-based chemotherapy. The main goals were to see if the drug could shrink tumors, how long the bene…
Matched conditions: PRIMARY PERITONEAL CANCER
Phase: PHASE2 • Sponsor: RemeGen Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Early trial tests Immune-Boosting drugs with chemo for tough cancers
Disease control CompletedThis small, early-stage study aimed to find out if it was safe to add one or two immunotherapy drugs (nivolumab and ipilimumab) to the standard chemotherapy used for advanced ovarian, fallopian tube, or primary peritoneal cancer. It involved 27 patients with advanced disease who …
Matched conditions: PRIMARY PERITONEAL CANCER
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Spanish study reviews cancer Drug's Real-Life performance
Knowledge-focused CompletedThis study looked back at medical records to understand how the drug rucaparib was used and performed for patients in Spain with ovarian, fallopian tube, or primary peritoneal cancer. It involved 51 adult women who received the drug through a special access program. The goal was …
Matched conditions: PRIMARY PERITONEAL CANCER
Sponsor: Grupo Español de Investigación en Cáncer de Ovario • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC